Noguchi M
Department of Neurosurgery, Tokyo Teishin Hospital.
No Shinkei Geka. 1998 Mar;26(3):225-32.
The incidence and death rate of subarachnoid hemorrhage (SAH) varies with age and sex. Female preponderance in the incidence of SAH is a well-known fact. However, the degree varies with age. Autopsy data, records of natural history of unruptured aneurysms, epidemiological and clinical cooperative studies have provided a great amount of information regarding the statistics of subarachnoid hemorrhage. But, each individual study has its own limitation, such as a bias in case selection in autopsy or clinical studies, predominance of aged population in the epidemiological cohort studies, limited frequency in the detection of unruptured aneurysms in the entire population. These shortcomings are reflected in the variability in the statistical data of these studies. Death records in 'Vital Statistics of Japan', published annually by Ministry of Health and Welfare of Japan, exhibit the numbers of deaths by cause (according to ICD-9 or 10 code), sex and age. In this study, we calculated the death rates of SAH (per 100,000) in 1993-1995 for each age group of both sexes based on the published data. Deaths from breast cancers and automobile accidents (AMA) were assessed in the same manner and compared with the results of SAH. The annual death rate of SAH for all people in Japan is 10.7 per 100,000 population and the average age of death is 65.6 y.o. The death rate is 8.2 for men, and 13.1 for women. Average age at the death is 60.2 y.o. in men, and 68.8 y.o. in women (p < 0.001). The age-adjusted death rate to 1985 Japanese population was 7.3 for men and 9.2 for women. Below age 60, rate of death caused by SAH is higher for men than women, but the ratio reverses in the population over 60. For men, the death rates after the age of 40, 50, 60 and 70 were 16.4, 20.4, 24.1 and 29.2 respectively. For women, the rates were 25.0, 32.8, 44.1 and 62.4. The female-to-male ratio of the death rates increases with age. Female sex should be considered as a risk factor for death from SAH. Number of deaths from breast cancers was about 90% of those from SAH in women. There was a difference in the age distribution; deaths caused by breast cancer tend to occur in younger age than those caused by SAHs. Mean age of death was 59.3 for breast cancer and 68.8 for SAH. Deaths caused by SAH is 1.4 times more likely to occur than those by breast cancer for a 50 year-old woman for the rest of her life, 1.9 times for a 60 y.o. woman, and 2.7 times for a 70 y.o. woman. Regular examination to detect breast cancer is widely performed in Japan among elderly women. We believe that a similar screening effort should be targeted for unruptured aneurysms from the standpoint of the medico-social cost. Automobile accidents (AMA) victimize as many people as SAH in Japan, about 13,000 per year. For males over the age of forty, AMA victims are more than those from SAH. However, conversely females' deaths from SAH occur three times frequently as those from AMAs. The fact should be taken into consideration when screening for unruptured aneurysms.
蛛网膜下腔出血(SAH)的发病率和死亡率随年龄和性别而变化。SAH发病率中女性占优势是一个众所周知的事实。然而,其程度随年龄而异。尸检数据、未破裂动脉瘤自然史记录、流行病学和临床合作研究提供了大量关于蛛网膜下腔出血统计的信息。但是,每项单独研究都有其自身的局限性,例如尸检或临床研究中病例选择的偏差、流行病学队列研究中老年人口占主导、整个人口中未破裂动脉瘤检测频率有限。这些缺点反映在这些研究统计数据的变异性中。日本厚生劳动省每年发布的《日本生命统计》中的死亡记录显示了按病因(根据ICD - 9或10编码)、性别和年龄划分的死亡人数。在本研究中,我们根据已发表的数据计算了1993 - 1995年各年龄组男女SAH的死亡率(每10万人)。以同样的方式评估乳腺癌和机动车事故(AMA)导致的死亡,并与SAH的结果进行比较。日本所有人群中SAH的年死亡率为每10万人口10.7例,平均死亡年龄为65.6岁。男性死亡率为8.2,女性为13.1。男性平均死亡年龄为60.2岁,女性为68.8岁(p < 0.001)。根据1985年日本人口调整后的死亡率,男性为7.3,女性为9.2。60岁以下,SAH导致的男性死亡率高于女性,但在60岁以上人群中这一比例相反。对于男性,40岁、50岁、60岁和70岁后的死亡率分别为16.4、20.4、24.1和29.2。对于女性,相应的比率为25.0、32.8、44.1和62.4。死亡率的女性与男性比率随年龄增加。女性应被视为SAH死亡的一个风险因素。女性乳腺癌死亡人数约为SAH死亡人数的90%。年龄分布存在差异;乳腺癌导致的死亡往往比SAH导致的死亡发生在更年轻的年龄。乳腺癌平均死亡年龄为59.3岁,SAH为68.8岁。对于一名50岁女性,其一生中SAH导致死亡的可能性是乳腺癌的1.4倍,60岁女性为1.9倍,70岁女性为2.7倍。在日本,针对老年女性广泛开展了定期检查以检测乳腺癌。我们认为,从医疗社会成本的角度出发,对于未破裂动脉瘤也应进行类似的筛查工作。在日本,机动车事故(AMA)造成的受害者人数与SAH相当,每年约13000人。对于40岁以上男性,AMA受害者多于SAH受害者。然而,相反的是,女性SAH死亡人数是AMA死亡人数的三倍。在筛查未破裂动脉瘤时应考虑到这一事实。